François Grand’Maison

10.3k total citations
28 papers, 1.6k citations indexed

About

François Grand’Maison is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, François Grand’Maison has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 10 papers in Neurology and 4 papers in Oncology. Recurrent topics in François Grand’Maison's work include Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (3 papers). François Grand’Maison is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Peripheral Neuropathies and Disorders (6 papers) and Polyomavirus and related diseases (3 papers). François Grand’Maison collaborates with scholars based in Canada, Italy and United States. François Grand’Maison's co-authors include Charles F. Bolton, G. Bryan Young, George A. Wells, Douglas W. Zochodne, William J. Sibbald, Masaaki Niino, Amit Bar‐Or, Mark S. Freedman, Michael J. Shkrum and Anthony Parkes and has published in prestigious journals such as New England Journal of Medicine, Brain and Neurology.

In The Last Decade

François Grand’Maison

27 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Grand’Maison Canada 16 650 530 325 271 262 28 1.6k
Kenneth C. Gorson United States 32 203 0.3× 2.2k 4.1× 132 0.4× 131 0.5× 74 0.3× 67 2.9k
Gaylan L. Rockswold United States 27 225 0.3× 1.3k 2.5× 112 0.3× 153 0.6× 64 0.2× 69 2.4k
Jaime Masjuán Spain 25 384 0.6× 1.0k 1.9× 29 0.1× 150 0.6× 135 0.5× 150 2.6k
Paul Nyquist United States 24 91 0.1× 897 1.7× 183 0.6× 78 0.3× 56 0.2× 96 1.9k
Uwe Malzahn Germany 24 147 0.2× 439 0.8× 57 0.2× 53 0.2× 106 0.4× 64 1.6k
Mathew R. Guilfoyle United Kingdom 26 210 0.3× 1.2k 2.2× 61 0.2× 94 0.3× 62 0.2× 70 2.0k
C. F. Bolton Canada 19 82 0.1× 1.5k 2.9× 453 1.4× 84 0.3× 50 0.2× 36 2.2k
Nevan G. Baldwin United States 15 411 0.6× 1.3k 2.4× 242 0.7× 46 0.2× 39 0.1× 34 2.3k
Paul Molyneux United Kingdom 12 808 1.2× 288 0.5× 15 0.0× 148 0.5× 272 1.0× 18 1.2k
Roger E. Kelley United States 20 183 0.3× 294 0.6× 30 0.1× 90 0.3× 37 0.1× 59 1.0k

Countries citing papers authored by François Grand’Maison

Since Specialization
Citations

This map shows the geographic impact of François Grand’Maison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Grand’Maison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Grand’Maison more than expected).

Fields of papers citing papers by François Grand’Maison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Grand’Maison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Grand’Maison. The network helps show where François Grand’Maison may publish in the future.

Co-authorship network of co-authors of François Grand’Maison

This figure shows the co-authorship network connecting the top 25 collaborators of François Grand’Maison. A scholar is included among the top collaborators of François Grand’Maison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Grand’Maison. François Grand’Maison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spelman, Tim, Dana Horáková, Serkan Özakbaş, et al.. (2022). Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity. Multiple Sclerosis and Related Disorders. 70. 104477–104477. 1 indexed citations
2.
Grand’Maison, François, et al.. (2018). Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches. Neural Regeneration Research. 13(11). 1871–1871. 20 indexed citations
3.
Metz, Luanne M., David K.B. Li, Anthony Traboulsee, et al.. (2017). Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis. New England Journal of Medicine. 376(22). 2122–2133. 140 indexed citations
4.
Kister, Ilya, Tim Spelman, Raed Alroughani, et al.. (2016). Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study. Journal of Neurology Neurosurgery & Psychiatry. 87(10). 1133–1137. 64 indexed citations
5.
Spelman, Timothy, Tomáš Kalinčík, Fabio Pellegrini, et al.. (2014). Comparison of Switching to Natalizumab Versus Remaining on Interferon-Beta or Glatiramer Acetate after On-Treatment MS Relapse Using Propensity-Matched Registry Data (P7.208). Neurology. 82(10_supplement). 1 indexed citations
6.
Spelman, Timothy, Fabio Pellegrini, Annie Zhang, et al.. (2013). Comparison of Patients Treated with Natalizumab and Interferon-beta/Glatiramer Using Propensity-Matched Multiple Sclerosis Registry Data (P01.211). Neurology. 80(7_supplement). 4 indexed citations
7.
Grand’Maison, François, Virender Bhan, Mark S. Freedman, et al.. (2013). Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(4). 527–535. 6 indexed citations
8.
Doward, Lynda, David Meads, John D. Fisk, et al.. (2010). International Development of the Unidimensional Fatigue Impact Scale (U-FIS). Value in Health. 13(4). 463–468. 18 indexed citations
9.
McKenna, Stephen P., Lynda Doward, James Twiss, et al.. (2010). International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Value in Health. 13(8). 946–951. 24 indexed citations
10.
Gray, Orla, David Jolley, Jeannette Lechner‐Scott, et al.. (2009). The Multiple Sclerosis Severity Score (MSSS) re-examined: EDSS rank stability in the MSBase dataset increases 5 years after onset of multiple sclerosis. Multiple Sclerosis Journal. 15(1). 140–140. 3 indexed citations
11.
Stüve, Olaf, Christina M. Marra, Amit Bar‐Or, et al.. (2006). Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis. Archives of Neurology. 63(10). 1383–1383. 220 indexed citations
12.
Niino, Masaaki, Caroline Bodner, Marie‐Lune Simard, et al.. (2006). Natalizumab effects on immune cell responses in multiple sclerosis. Annals of Neurology. 59(5). 748–754. 168 indexed citations
13.
Freedman, Mark S., et al.. (2004). Treatment Optimization in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 31(2). 157–168. 81 indexed citations
14.
Grand’Maison, François. (1998). Methods of Testing Neuromuscular Transmission in the Intensive Care Unit. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 25(S1). S36–S39. 3 indexed citations
15.
Bolton, Charles F., François Grand’Maison, Anthony Parkes, & Michael J. Shkrum. (1992). Needle electromyography of the diaphragm. Muscle & Nerve. 15(6). 678–681. 91 indexed citations
16.
Reiher, Jean, François Grand’Maison, & C. P. Leduc. (1992). Partial status epilepticus: short-term prediction of seizure outcome from on-line EEG analysis. Electroencephalography and Clinical Neurophysiology. 82(1). 17–22. 5 indexed citations
17.
Grand’Maison, François, Thomas E. Feasby, Angelika F. Hahn, & Wilma J. Koopman. (1992). RECURRENT GUILLAIN-BARRÉ SYNDROME. Brain. 115(4). 1093–1106. 47 indexed citations
18.
Grand’Maison, François, Jean Reiher, & C. P. Leduc. (1991). Retrospective inventory of EEG abnormalities in partial status epilepticus. Electroencephalography and Clinical Neurophysiology. 79(4). 264–270. 29 indexed citations
19.
Zochodne, Douglas W., Charles F. Bolton, François Grand’Maison, et al.. (1991). Peripheral Nerve Function in Sepsis and Multiple Organ Failure. CHEST Journal. 99(1). 176–184. 397 indexed citations
20.
Grand’Maison, François, Jean Reiher, Marcel Lebel, & J. Rivest. (1989). Transient Anosognosia for Episodic Hemiparesis: A Singular Manifestation of TIAs and Epileptic Seizures. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 16(2). 203–205. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth C. Gorson Breakdown of academic impact, for papers by Gaylan L. Rockswold Breakdown of academic impact, for papers by Jaime Masjuán Breakdown of academic impact, for papers by Paul Nyquist Breakdown of academic impact, for papers by Uwe Malzahn Breakdown of academic impact, for papers by Mathew R. Guilfoyle Breakdown of academic impact, for papers by C. F. Bolton Breakdown of academic impact, for papers by Nevan G. Baldwin Breakdown of academic impact, for papers by Paul Molyneux Breakdown of academic impact, for papers by Roger E. Kelley
Rankless by CCL
2026